Cargando…

A Patient with Rheumatoid Arthritis under Methotrexate and Etanercept Treatment Presenting with Fever and Pancytopenia: An Unexpected Guest

Leishmania species induce chronic intracellular parasitism, while visceral leishmaniasis can become fatal, if left untreated. Patients with rheumatoid arthritis might feature a genetic predisposition to infection from Leishmania species, besides the status of immunosuppression. Several cases of visc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patoulias, Dimitrios, Papachristou, Savvas, Gouridou, Evgenia, Stamou, Dafni, Chissan, Sofia, Bakatselos, Spyridon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369276/ https://www.ncbi.nlm.nih.gov/pubmed/34447913 http://dx.doi.org/10.31138/mjr.32.2.160

Ejemplares similares

All That Glitters is not Gold! A Case of Concomitant Acute Pericarditis and Subsegmental Pulmonary Embolism
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Methotrexate Induced Pancytopenia
por: Gonzalez-Ibarra, Fernando, et al.
Publicado: (2014)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
por: Gallo, G, et al.
Publicado: (2016)

The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis
por: Pope, Janet E, et al.
Publicado: (2014)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

An unexpected guest
por: Kissou, Amina, et al.
Publicado: (2017)

Mucocutaneous Ulcerations and Pancytopenia due to Methotrexate Overdose
por: Knoll, Katharina, et al.
Publicado: (2016)

Low-Dose Methotrexate Toxicity Presenting as Pancytopenia
por: Dhillon, Gundip S, et al.
Publicado: (2022)

Oral non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate
por: Georgakopoulou, Eleni A., et al.
Publicado: (2015)

Changes in Plasma IL-6, Plasma VEGF and Serum YKL-40 During Treatment with Etanercept and Methotrexate or Etanercept Alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy
por: Knudsen, Lene Surland, et al.
Publicado: (2009)

Methotrexate-induced pancytopenia in a patient with ectopic pregnancy
por: Shao, Shih-Chieh, et al.
Publicado: (2016)

Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error
por: Amissah-Arthur, Maame-Boatemaa, et al.
Publicado: (2020)

Etanercept/methotrexate: COVID-19: case report
Publicado: (2020)

Etanercept/methotrexate: Treatment failure: case report
Publicado: (2021)

The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry
por: Becciolini, Andrea, et al.
Publicado: (2016)

Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
por: Smolen, Josef S., et al.
Publicado: (2018)

Unexpected cause of pancytopenia in a teenager with Noonan syndrome
por: Perrone, Salvatore, et al.
Publicado: (2021)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
por: Chen, Hsin-Hua, et al.
Publicado: (2016)

Effects of methotrexate and etanercept treatment in moderate and severe psoriasis
por: Benites, Elizabeth, et al.
Publicado: (2022)

A Case of Pancytopenia Secondary to Low-Dose Pulse Methotrexate Therapy in a Patient with Rheumatoid Arthritis and Renal Insufficiency
por: Park, Geun Tae, et al.
Publicado: (1999)

Evaluation of the Efficacy of Combined Therapy of Methotrexate and Etanercept versus Methotrexate as a Mono-Therapy
por: Rexhepi, Sylejman, et al.
Publicado: (2018)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate
por: Kavanaugh, A, et al.
Publicado: (2008)

Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis
por: Keystone, Edward C., et al.
Publicado: (2016)

Cost-effectiveness analysis of etanercept plus methotrexate vs triple therapy in treating Chinese rheumatoid arthritis patients
por: Shi, Zhi-Chao, et al.
Publicado: (2020)

Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate
por: Tkacz, Joseph, et al.
Publicado: (2020)

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
por: Incerti, Devin, et al.
Publicado: (2020)

Methotrexate-Induced Septicemia With Severe Pancytopenia and Diffuse Cutaneous Ulcerative Lesions
por: Tiewsoh, Iadarilang, et al.
Publicado: (2021)

Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious
por: van Vollenhoven, Ronald F, et al.
Publicado: (2003)

Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach
por: Obry, Antoine, et al.
Publicado: (2014)

Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis
por: Bonafede, Machaon, et al.
Publicado: (2015)

Methotrexate-induced nonhealing cutaneous ulcers in a nonpsoriatic patient without pancytopenia
por: Tekur, Venkatesh Krishnamurthy
Publicado: (2016)

Pancytopenia Resulting From Low-Dose Methotrexate Use: A Diagnostic Challenge
por: Hassan, Syed Wajih Ul
Publicado: (2021)

An Unusual Presentation of a Patient With Low-Dose Methotrexate Causing Colitis and Pancytopenia
por: R, Ramya, et al.
Publicado: (2022)

Etanercept plus methotrexate: An effective combination therapy for recalcitrant pemphigus vulgaris
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a1s4vgbv7g8okpicffuui8lrfj